Cargando…

Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery

INTRODUCTION: Long-term stability of therapeutic candidates is necessary toward their clinical applications. For most nanoparticle systems formulated in aqueous solutions, lyophilization or freeze-drying is a common method to ensure long-term stability. While lyophilization of lipid, polymeric, or i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngamcherdtrakul, Worapol, Sangvanich, Thanapon, Reda, Moataz, Gu, Shenda, Bejan, Daniel, Yantasee, Wassana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045907/ https://www.ncbi.nlm.nih.gov/pubmed/30022824 http://dx.doi.org/10.2147/IJN.S164393

Ejemplares similares

Removal of a gadolinium based contrast agent by a novel sorbent hemoperfusion in a chronic kidney disease (CKD) rodent model
por: Ngamcherdtrakul, Worapol, et al.
Publicado: (2019)

Lanthanide-Loaded Nanoparticles as Potential Fluorescent and Mass Probes for High-Content Protein Analysis
por: Ngamcherdtrakul, Worapol, et al.
Publicado: (2019)

Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment
por: Gu, Shenda, et al.
Publicado: (2018)

Therapeutic siRNA for drug-resistant HER2-positive breast cancer
por: Gu, Shenda, et al.
Publicado: (2016)

Novel Oral Detoxification of Mercury, Cadmium, And Lead with Thiol-Modified Nanoporous Silica
por: Sangvanich, Thanapon, et al.
Publicado: (2014)

Correction to Novel Oral Detoxification of Mercury, Cadmium, and Lead with Thiol-Modified Nanoporous Silica
por: Sangvanich, Thanapon, et al.
Publicado: (2014)

Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles
por: Morry, Jingga, et al.
Publicado: (2016)

Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment
por: Reda, Moataz, et al.
Publicado: (2022)

Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery
por: Slita, Anna, et al.
Publicado: (2018)

High-Capacity Mesoporous Silica Nanocarriers of siRNA for Applications in Retinal Delivery
por: Ultimo, Amelia, et al.
Publicado: (2023)

Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment
por: Xie, Xiaowei, et al.
Publicado: (2023)

Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing
por: Dohmen, Christian, et al.
Publicado: (2012)

Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of siRNA Cancer Therapeutics
por: Shen, Jianliang, et al.
Publicado: (2014)

Optimized siRNA-PEG Conjugates for Extended Blood Circulation and Reduced Urine Excretion in Mice
por: Iversen, Frank, et al.
Publicado: (2013)

Effect of Cationic Lipid Type in Folate-PEG-Modified Cationic Liposomes on Folate Receptor-Mediated siRNA Transfection in Tumor Cells
por: Hattori, Yoshiyuki, et al.
Publicado: (2019)

Mesoporous silica-coated silver nanoparticles as ciprofloxacin/siRNA carriers for accelerated infected wound healing
por: Liu, Qiqi, et al.
Publicado: (2022)

Novel PAMAM-PEG-Peptide Conjugates for siRNA Delivery Targeted to the Transferrin and Epidermal Growth Factor Receptors
por: Urbiola, Koldo, et al.
Publicado: (2018)

Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment
por: Wang, Dandan, et al.
Publicado: (2017)

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012)

Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer
por: Darvishi, Behrad, et al.
Publicado: (2017)

Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer
por: Zhuang, Jialang, et al.
Publicado: (2021)

siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells
por: Heidari, Razieh, et al.
Publicado: (2021)

Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021)

Overcoming the non-kinetic activity of EGFR1 using multi-functionalized mesoporous silica nanocarrier for in vitro delivery of siRNA
por: Parnian, Javad, et al.
Publicado: (2022)

Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene-silencing effects and siRNA biodistribution in mice
por: Hattori, Yoshiyuki, et al.
Publicado: (2020)

Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery
por: Prabhakar, Neeraj, et al.
Publicado: (2016)

Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction]
Publicado: (2022)

Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA
por: Malhotra, Meenakshi, et al.
Publicado: (2013)

Chaperonin–Dendrimer Conjugates for siRNA Delivery
por: Nussbaumer, Martin G., et al.
Publicado: (2016)

Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy
por: Chen, Yijie, et al.
Publicado: (2015)

Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy
por: Shahidi, Maryamsadat, et al.
Publicado: (2022)

In Vivo GFP Knockdown by Cationic Nanogel-siRNA Polyplexes
por: Shrivats, Arun R., et al.
Publicado: (2015)

Amylose-Based Cationic Star Polymers for siRNA Delivery
por: Nishimura, Tomoki, et al.
Publicado: (2015)

Cationic Magnetite Nanoparticles for Increasing siRNA Hybridization Rates
por: Prilepskii, Artur Y., et al.
Publicado: (2020)

Strategy for Conjugating Oligopeptides to Mesoporous Silica Nanoparticles Using Diazirine-Based Heterobifunctional Linkers
por: Khan, Md Arif, et al.
Publicado: (2022)

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
por: Höbel, Sabrina, et al.
Publicado: (2011)

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates
por: Foster, Donald J., et al.
Publicado: (2018)

Cylindrical Microparticles Composed of Mesoporous Silica Nanoparticles for the Targeted Delivery of a Small Molecule and a Macromolecular Drug to the Lungs: Exemplified with Curcumin and siRNA
por: Fischer, Thorben, et al.
Publicado: (2021)

Biofunctionalized Decellularized Tissue-Engineered Heart Valve with Mesoporous Silica Nanoparticles for Controlled Release of VEGF and RunX2-siRNA against Calcification
por: Yu, Wenpeng, et al.
Publicado: (2023)

Molecular Umbrella Conjugate for the Ocular Delivery of siRNA
por: Janout, Vaclav, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cl476q8lec7i5qckultffp3ard